Kylee Maclachlan
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
-
- Peptidase Inhibition and Analysis
Papers in
- Hematology 38
- Multiple Myeloma Research and Treatments 38
-
- Protein Degradation and Inhibitors 14
- Ubiquitin and proteasome pathways 3
- Glycosylation and Glycoproteins Research 2
- Co-authors
- Ola Landgren (23 shared papers)Benjamin Diamond (14 shared papers)Simon J. Harrison (5 shared papers)Ross D. Hannan (4 shared papers)Nadine Hein (3 shared papers)Francesco Maura (15 shared papers)Gretchen Poortinga (4 shared papers)Emma Link (1 shared paper)
- Journals
- Blood (19 papers)Journal of Clinical Oncology (6 papers)Clinical Cancer Research (2 papers)Best Practice & Research Clinical Haematology (2 papers)Blood Cancer Journal (2 papers)
- Partner nations
- United StatesAustraliaGermany
In The Last Decade
Kylee Maclachlan
39 papers receiving 375 citations
Peers
Comparison fields: 5 of 46
- Hematology 175
- Oncology 108
- Molecular Biology 251
- Internal Medicine 8
- Cancer Research 27
Countries citing papers authored by Kylee Maclachlan
This map shows the geographic impact of Kylee Maclachlan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kylee Maclachlan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kylee Maclachlan more than expected).
Fields of papers citing papers by Kylee Maclachlan
This network shows the impact of papers produced by Kylee Maclachlan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kylee Maclachlan. The network helps show where Kylee Maclachlan may publish in the future.
Co-authors
The 25 scholars most cited alongside Kylee Maclachlan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 144 | |
| 2 | 2020 | 31 | |
| 3 | 2021 | 30 | |
| 4 | 2021 | 28 | |
| 5 | 2020 | 19 | |
| 6 | 2021 | 16 | |
| 7 | 2019 | 12 | |
| 8 | 2024 | 10 | |
| 9 | 2023 | 8 | |
| 10 | 2022 | 8 | |
| 11 | 2021 | 7 | |
| 12 | 2024 | 7 | |
| 13 | 2020 | 7 | |
| 14 | 2024 | 6 | |
| 15 | 2022 | 4 | |
| 16 | 2022 | 4 | |
| 17 | 2017 | 3 | |
| 18 | 2023 | 3 | |
| 19 | 2022 | 3 | |
| 20 | 2024 | 3 |
About Kylee Maclachlan
Kylee Maclachlan is a scholar working on Hematology, Molecular Biology, Oncology, Cancer Research and Genetics, having authored 45 papers that have together received 380 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (38 papers), Protein Degradation and Inhibitors (14 papers), Cancer Genomics and Diagnostics (5 papers), Peptidase Inhibition and Analysis (5 papers), Cancer Treatment and Pharmacology (4 papers), Ubiquitin and proteasome pathways (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Hematology (175 citations), Oncology (108 citations), Molecular Biology (251 citations), Internal Medicine (8 citations) and Cancer Research (27 citations). Kylee Maclachlan has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Ola Landgren, Benjamin Diamond, Simon J. Harrison, Ross D. Hannan, Nadine Hein, Francesco Maura, Gretchen Poortinga, Emma Link, Amit Khot and Andrew Fellowes. Their work appears in journals such as Blood, Journal of Clinical Oncology, Clinical Cancer Research, Best Practice & Research Clinical Haematology and Blood Cancer Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.